Drugmakers cannot raise price of non-scheduled formulations by more than 10 pc yearly: Minister informs Parliament Medical Dialogues Bureau5 July 2019 12:28 PMAs per provisions of DPCO, all manufacturers of Scheduled medicines (branded or generic) have to sell their products within the ceiling price fixed by...
Relief to Foreign Drugmakers: No price cap on innovative drugs for first five years Farhat Nasim5 Jan 2019 5:14 AMNew Delhi: Through a recent Gazette notice the Central Government has made amendments to the Drugs Prices Control Orders (DPCO),2013 which aim to...
Launch new drugs without prior price approval: NPPA issues guidelines Ruby Khatun Khatun2 Dec 2017 6:55 AMThrough a recent notification the National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and...
NPPA invites representation and suggestion on Coronary Stents Ruby Khatun Khatun14 Nov 2017 10:59 AMThrough a recent notification Government of India, Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, and National Pharmaceutical...
NPPA says Abbott can discontinue Xience Alpine stent in a year, check out details Ruby Khatun Khatun27 Sept 2017 7:12 AMNew Delhi: Through a recent notice, Government of India, Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, and National...
NPPA allows Abbott to withdraw bioresorbable stent from India Ruby Khatun Khatun22 Sept 2017 11:30 AMNew Delhi: Through a recent notice, Government of India , Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, and National...
Cannot exceed 8 percent trade margin on Stents: NPPA Ruby Khatun Khatun4 Aug 2017 12:30 PMNew Delhi: NPPA has taken a step ahead to prevent distributors from grabbing higher profits and manipulating trade margins on coronary stents than the...
